Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease

Regulatory Peptides

Volumn 165, Issue 2-3, 2010, Pages 210-217

  Shibasaki, Ikuko ^a   Nishikimi, Toshio ^a   Mochizuki, Yoshihiko ^a   Yamada, Yasuyuki ^a   Yoshitatsu, Masao ^a   Inoue, Yuho ^a   Kuwata, Toshiyuki ^a   Ogawa, Hironaga ^a   Tsuchiya, Go ^a   Ishimitsu, Toshihiko ^a   Fukuda, Hirotsugu ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adipokine; Adrenomedullin; Coronary artery disease; Cytokine; Epicardial adipose tissue; Natriuretic peptide receptor C

Indexed keywords

ADIPONECTIN; ADRENOMEDULLIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NATRIURETIC PEPTIDE RECEPTOR C; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EPICARDIUM; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; ADRENOMEDULLIN; AGED; CHEMOKINE CCL2; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; PERICARDIUM; RECEPTORS, ATRIAL NATRIURETIC FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649843780     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.07.169     Document Type: Article

References (40)

1. Tank L.B., Bagger Y.Z., Alexandersen P., Larsen P.J., Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic elderly women. Circulation 2003, 107:1626-1631.
2. Kissebah A.H., Krakower G.R. Regional adiposity and morbidity. Physiol Rev 1994, 74:761-811.
3. Baker A.R., Silva N.F., Quinn D.W., Harte A.L., Pagano D., Bonser R.S., Kumar S., McTernan P.G. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006, 5:1-7.
4. Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., Sarov-Blat L., O'Brien S., Keiper E.A., Johnson A.G., Martin J., Goldstein B.J., Shi Y. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466.
5. Iacobellis G., Pistilli D., Gucciardo M., Leonetti F., Miraldi F., Brancaccio G., Gallo P., Tiziana di Gioia C.R. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005, 29:251-255.
6. Eiras S., Teijeira-Fernández E., Shamagian L.G., Fernandez A.L., Vazquez-Boquete A., Gonzalez-Juanatey J.R. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine 2008, 43:174-180.
7. Cheng K.H., Chu C.S., Lee K.T., Lin T.H., Hsieh C.C., Chiu C.C., Voon W.C., Sheu S.H., Lai W.T. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes 2008, 32:268-274.
8. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
9. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-E751.
10. Iemura-Inaba C., Nishikimi T., Akimoto K., Yoshihara F., Minamino N., Matsuoka H. Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytes. Am J Physiol Regul Integr Comp Physiol 2008, 295:R1376-R1384.
11. Sengens C., Berlan M., De Glisezinski I., Lafontan M., Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 2000, 14:1345-1351.
12. Iacobellis G., di Gioia C.R., Di Vito M., Petramala L., Cotesta D., De Santis V., Vitale D., Tritapepe L., Letizia C. Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Horm Metab Res 2009, 41:855-860.
13. Shimokawa H., Ito A., Fukumoto Y., Kadokami T., Nakaike R., Sakata M., Takayanagi T., Egashira K., Takeshita A. Chronic treatment with interleukin-1_induces coronary intimal lesions and vasospastic responses in pigs in vivo. J Clin Invest 1996, 97:769-776.
14. Nishikimi T., Miyata A., Horio T., Yoshihara F., Nagaya N., Takishita S., Yutani C., Matsuo H., Matsuoka H., Kangawa K. Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am J Physiol Heart Circ Physiol 2000, 279:H3031-H3039.
15. Nishikimi T., Hagaman J.R., Takahashi N., Kim H.S., Matsuoka H., Smithies O., Maeda N. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene. Cardiovasc Res 2005, 66:94-103.
16. Wattjes M.P., Krauter J., Nagel S., Heidenreich O., Ganser A., Heil G. Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia. Leukemia 2000, 14:329-335.
17. Fogelstrand L., Hulthe J., Hulten L.M., Wiklund O., Fagerberg B. Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance. Diabetologia 2004, 47:1948-1952.
18. Fisher F.M., McTernan P.G., Valsamakis G., Chetty R., Harte A.L., Anwar A.J., Starcynski J., Crocker J., Barnett A.H., McTernan C.L., Kumar S. Differences in adiponectin protein expression: effect of fat depots and type 2diabetic status. Horm Metab Res 2002, 34:650-654.
19. Morimoto C., Tsujita T., Okuda H. Norepinephrine-induced lipolysis in rat fat cells from visceral and subcutaneous sites: role of hormone-sensitive lipase and lipid droplets. J Lipid Res 1997, 38:132-138.
20. Nishikimi T., Iemura-Inaba C., Akimoto K., Ishikawa K., Koshikawa S., Matsuoka H. Stimulatory and inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes. Regul Pept 2009, 153:56-63.
21. Fukai N., Yoshimoto T., Sugiyama T., Ozawa N., Sato R., Shichiri M., Hirata Y. Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues. Am J Physiol Endocrinol Metab 2005, 288:E56-E62.
22. Li Y., Totsune K., Takeda K., Furuyama K., Shibahara S., Takahashi K. Decreased expression of adrenomedullin during adipocyte-differentiation of 3T3-L1 cells. Hypertens Res 2003, 26(Suppl):S41-S44.
23. Nomura I., Kato J., Tokashiki M., Kitamura K. Increased plasma levels of the mature and intermediate forms of adrenomedullin in obesity. Regul Pept 2009, 158:127-131.
24. Minami J., Nishikimi T., Ishimitsu T., Makino Y., Kawano Y., Takishita S., Kangawa K., Matsuoka H. Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. J Cardiovasc Pharmacol 2000, 36(Suppl 2):S83-S86.
25. Suzuki Y., Horio T., Nonogi H., Hayashi T., Kitamura K., Eto T., Kangawa K., Kawano Y. Adrenomedullin as a sensitive marker for coronary and peripheral arterial complications in patients with atherosclerotic risks. Peptides 2004, 25:1321-1326.
26. Kato J., Tsuruda T., Kita T., Kitamura K., Eto T. Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005, 25:2480-2487.
27. Silaghi A., Achard V., Paulmyer-Lacroix O., Scridon T., Tassistro V., Duncea I., Clment K., Dutour A., Grino M. Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status. Am J Physiol Endocrinol Metab 2007, 293:E1443-E1450.
28. Dess-Fulgheri P., Sarzani R., Rappelli A. The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects. J Nephrol 1998, 11:296-299.
29. Rose R.A., Giles W.R. Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol 2008, 586:353-366.
30. Mehra M.R., Uber P.A., Park M.H., Scott R.L., Ventura H.O., Harris B.C., Frohlich E.D. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004, 43:1590-1595.
31. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Wilson P.W., Vasan R.S. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004, 109:594-600.
32. Lai C.P., Egashira K., Tashiro H., Narabayashi H., Koyanagi S., Imaizumi T., Takeshita A. Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris. Circulation 1993, 87:144-151.
33. -/- mice. Arterioscler Thromb Vasc Biol 2003, 23:1077-1082.
34. Rose R.A., Giles W.R. Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol 2008, 586:353-366.
35. Huntley B.K., Sandberg S.M., Noser J.A., Cataliotti A., Redfield M.M., Matsuda Y., Burnett J.C. BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors. J Cell Physiol 2006, 209:943-949.
36. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005, 96:939-949.
37. Bodary P.F., Gu S., Shen Y., Hasty A.H., Buckler J.M., Eitzman D.T. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005, 25:119-122.
38. Bouloumie A., Marumo T., Lafontan M., Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999, 13:1231-1238.
39. Yamagishi S.I., Edelstein D., Du X.L., Kaneda Y., Guzman M., Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001, 276:25096-25100.
40. Quehenberger P., Exner M., Sunder-Plassmann R., Ruzicka K., Bieglmayer C., Endler G., Muellner C., Speiser W., Wagner O. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res 2002, 90:711-718.